Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.71 |
| ▸ | LMNA | P02545 | 2/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.67 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | DGKA | P23743 | 2/20 | 0.60 |
| ▸ | PRKCA | P17252 | 3/20 | 0.58 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.58 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.58 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.58 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.58 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.58 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.58 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.58 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.58 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.58 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.58 |
| ▸ | PAM | P19021 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26675322 | 1.00 | MAPT (0.71) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL8800631 | 1.00 | MAPT (0.71) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL11201945 | 1.00 | MAPT (0.71) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL22855717 | 1.00 | MAPT (0.71) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL1240628 | 0.93 | LMNA (0.69) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL435834 | 0.93 | LMNA (0.69) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL312968 | 0.93 | LMNA (0.69) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL4230904 | 0.93 | LMNA (0.69) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL5058739 | 0.93 | LMNA (0.69) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL6880106 | 0.93 | LMNA (0.69) | MAPTLMNAKDM4EDUSP3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200405588-A1 | TOPICAL TREATMENTS OF BATH TISSUES | GPCP IP HOLDINGS LLC (US) | 2020-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200405588-A1 | TOPICAL TREATMENTS OF BATH TISSUES | CUTA, CEL, PRKACG | MAPT 3304/4885LMNA 4112/4885KDM4E 1728/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.